Transplant tolerance through costimulation blockade - Are we there yet?

Frontiers in Bioscience

Volumn 12, Issue 8, 2007, Pages 2935-2946

  Vadivel, Nidyanandh ^a   Trikudanathan, Subbulaxmi ^a   Chandraker, Anil ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CD28 family; Costimulation blockade; Negative costimulatory pathway; Positive costimulatory pathway; Review; TNF family; Transplant tolerance

Indexed keywords

LEUKOCYTE ANTIGEN;

ANIMAL; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; REVIEW; TRANSPLANTATION;

ANIMALS; ANTIGENS, CD; HUMANS; IMMUNE TOLERANCE; TRANSPLANTATION;

EID: 34347256722     PISSN: 27686701     EISSN: 27686698     Source Type: Journal    
DOI: 10.2741/2283     Document Type: Review

References (110)

1. Bretscher, P. & M. Cohn: A theory of self-nonself discrimination. Science, 169, 1042-9 (1970)
2. Lafferty, K. J. & A. J. Cunningham: A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci, 53, 27-42 (1975)
3. Sayegh, M. H. & C. B. Carpenter: Transplantation 50 years later-progress, challenges, and promises. N Engl J Med, 351, 2761-6 (2004) (Pubitemid 39665333)
4. Meier-Kriesche, H. U., J. D. Schold, T. R. Srinivas & B. Kaplan: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant, 4, 378-83 (2004) (Pubitemid 38282293)
5. Magee, C. & M. Pascual: The growing problem of chronic renal failure after transplantation of a nonrenal organ. N Engl J Med, 349, 994-6 (2003) (Pubitemid 37064774)
6. Gimmi, C. D., G. J. Freeman, J. G. Gribben, G. Gray & L. M. Nadler: Human T-cell clonal anergy is induced by antigen presentation in the absence of B7 costimulation. Proc Natl Acad Sci U S A, 90, 6586-90 (1993) (Pubitemid 23207258)
7. Noel, P. J., L. H. Boise, J. M. Green & C. B. Thompson: CD28 costimulation prevents cell death during primary T cell activation. J Immunol, 157, 636-42 (1996) (Pubitemid 26231365)
8. Khoury, S. J. & M. H. Sayegh: The roles of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity, 20, 529-38 (2004) (Pubitemid 38638123)
9. Rothstein, D. M. & M. H. Sayegh: T-cell costimulatory pathways in allograft rejection and tolerance. Immunol Rev, 196, 85-108 (2003) (Pubitemid 37468106)
10. Kroczek, R. A., H. W. Mages & A. Hutloff: Emerging paradigms of T-cell co-stimulation. Curr Opin Immunol, 16, 321-7 (2004) (Pubitemid 38595371)
11. Sharpe, A. H. & G. J. Freeman: The B7-CD28 superfamily. Nat Rev Immunol, 2, 116-26 (2002) (Pubitemid 37323235)
12. Bickerstaff, A. A., J. J. Wang, R. P. Pelletier & C. G. Orosz: The graft helps to define the character of the alloimmune response. Transpl Immunol, 9, 137-41 (2002) (Pubitemid 34863375)
13. Gasser, M., A. M. Waaga-Gasser, J. E. Kist-van Holthe, X. Yuan, S. M. Lenhard, K. A. Abdallah & A. Chandraker: Chronic rejection: insights from a novel immunosuppressive-free model of kidney transplantation. J Am Soc Nephrol, 15, 687-94 (2004) (Pubitemid 38294798)
14. Monk, N. J., R. E. Hargreaves, E. Simpson, J. P. Dyson & S. Jurcevic: Transplant tolerance: models, concepts and facts. J Mol Med, 84, 295-304 (2006)
15. Linsley, P. S. & J. A. Ledbetter: The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol, 11, 191-212 (1993) (Pubitemid 23115006)
16. June, C. H., J. A. Bluestone, L. M. Nadler & C. B. Thompson: The B7 and CD28 receptor families. Immunol Today, 15, 321-31 (1994) (Pubitemid 24231747)
17. McAdam, A. J., A. N. Schweitzer & A. H. Sharpe: The role of B7 co-stimulation in activation and differentiation of CD4+ and CD8+ T cells. Immunol Rev, 165, 231-47 (1998) (Pubitemid 28524215)
18. Alegre, M. L., K. A. Frauwirth & C. B. Thompson: T-cell regulation by CD28 and CTLA-4. Nat Rev Immunol, 1, 220-8 (2001) (Pubitemid 33741960)
19. Collins, A. V., D. W. Brodie, R. J. Gilbert, A. Iaboni, R. Manso-Sancho, B. Walse, D. I. Stuart, P. A. van der Merwe & S. J. Davis: The interaction properties of costimulatory molecules revisited. Immunity, 17, 201-10 (2002) (Pubitemid 35245962)
20. Stamper, C. C., Y. Zhang, J. F. Tobin, D. V. Erbe, S. Ikemizu, S. J. Davis, M. L. Stahl, J. Seehra, W. S. Somers & L. Mosyak: Crystal structure of the B7-1/CTLA-4 complex that inhibits human immune responses. Nature, 410, 608-11 (2001) (Pubitemid 32267208)
21. Szot, G. L., P. Zhou, A. H. Sharpe, G. He, O. Kim, K. A. Newell, J. A. Bluestone & J. R. Thistlethwaite, Jr.: Absence of host B7 expression is sufficient for long-term murine vascularized heart allograft survival. Transplantation, 69, 904-9 (2000) (Pubitemid 30174119)
22. Mandelbrot, D. A., A. J. McAdam & A. H. Sharpe: B7-1 or B7-2 is required to produce the lymphoproliferative phenotype in mice lacking cytotoxic T lymphocyte-associated antigen 4 (CTLA-4). J Exp Med, 189, 435-40 (1999) (Pubitemid 29063264)
23. Yamada, A., K. Kishimoto, V. M. Dong, M. Sho, A. D. Salama, N. G. Anosova, G. Benichou, D. A. Mandelbrot, A. H. Sharpe, L. A. Turka, H. Auchincloss, Jr. & M. H. Sayegh: CD28-independent costimulation of T cells in alloimmune responses. J Immunol, 167, 140-6 (2001) (Pubitemid 32567771)
24. Maier, S., C. Tertilt, N. Chambron, K. Gerauer, N. Huser, C. D. Heidecke & K. Pfeffer: Inhibition of natural killer cells results in acceptance of cardiac allografts in CD28-/-mice. Nat Med, 7, 557-62 (2001) (Pubitemid 32448322)
25. Dong, V. M., X. Yuan, A. J. Coito, A. M. Waaga, M. H. Sayegh & A. Chandraker: Mechanisms of targeting CD28 by a signaling monoclonal antibody in acute and chronic allograft rejection. Transplantation, 73, 1310-7 (2002) (Pubitemid 34454281)
26. Montgomery, S. P., H. Xu, D. K. Tadaki, A. Celniker, L. C. Burkly, J. D. Berning, F. Cruzata, E. A. Elster, G. Gray, R. L. Kampen, S. J. Swanson, D. M. Harlan & A. D. Kirk: Combination induction therapy with monoclonal antibodies specific for CD80, CD86, and CD154 in nonhuman primate renal transplantation. Transplantation, 74, 1365-9 (2002) (Pubitemid 35379537)
27. Larsen, C. P. & T. C. Pearson: The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr Opin Immunol, 9, 641-7 (1997) (Pubitemid 27485291)
28. Henn, V., J. R. Slupsky, M. Grafe, I. Anagnostopoulos, R. Forster, G. Muller-Berghaus & R. A. Kroczek: CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature, 391, 591-4 (1998) (Pubitemid 28157601)
29. Rossini, A. A., D. C. Parker, N. E. Phillips, F. H. Durie, R. J. Noelle, J. P. Mordes & D. L. Greiner: Induction of immunological tolerance to islet allografts. Cell Transplant, 5, 49-52 (1996) (Pubitemid 26076602)
30. Larsen, C. P., E. T. Elwood, D. Z. Alexander, S. C. Ritchie, R. Hendrix, C. Tucker-Burden, H. R. Cho, A. Aruffo, D. Hollenbaugh, P. S. Linsley, K. J. Winn & T. C. Pearson: Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature, 381, 434-8 (1996) (Pubitemid 26162734)
31. Larsen, C. P., D. Z. Alexander, D. Hollenbaugh, E. T. Elwood, S. C. Ritchie, A. Aruffo, R. Hendrix & T. C. Pearson: CD40-gp39 interactions play a critical role during allograft rejection. Suppression of allograft rejection by blockade of the CD40-gp39 pathway. Transplantation, 61, 4-9 (1996) (Pubitemid 26033938)
32. Hancock, W. W., M. H. Sayegh, X. G. Zheng, R. Peach, P. S. Linsley & L. A. Turka: Costimulatory function and expression of CD40 ligand, CD 80, and CD86 in vascularized murine cardiac allograft rejection. Proc Natl Acad Sci U S A, 93, 13967-72 (1996) (Pubitemid 26424229)
33. Blazar, B. R., P. A. Taylor, A. Panoskaltsis-Mortari, J. Buhlman, J. Xu, R. A. Flavell, R. Korngold, R. Noelle & D. A. Vallera: Blockade of CD40 ligand-CD40 interaction impairs CD4+ T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol, 158, 29-39 (1997) (Pubitemid 127483838)
34. Shimizu, K., U. Schonbeck, F. Mach, P. Libby & R. N. Mitchell: Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis. J Immunol, 165, 3506-18 (2000)
35. Wekerle, T., J. Kurtz, H. Ito, J. V. Ronquillo, V. Dong, G. Zhao, J. Shaffer, M. H. Sayegh & M. Sykes: Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med, 6, 464-9 (2000) (Pubitemid 30208167)
36. Markees, T. G., N. E. Phillips, E. J. Gordon, R. J. Noelle, L. D. Shultz, J. P. Mordes, D. L. Greiner & A. A. Rossini: Long-term survival of skin allografts induced by donor splenocytes and anti-CD154 antibody in thymectomized mice requires CD4 (+) T cells, interferongamma, and CTLA4. J Clin Invest, 101, 2446-55 (1998) (Pubitemid 28270439)
37. Markees, T., N. Phillips, E. Gordon, R. J. Noelle, J. P. Mordes, D. L. Greiner & A. A. Rossini: Improved skin allograft tolerance induced by treatment with donor splenocytes and an extended course of anti-CD154 monoclonal antibody. Transplant Proc, 30, 2444-6 (1998) (Pubitemid 28399567)
38. Li, Y., X. C. Li, X. X. Zheng, A. D. Wells, L. A. Turka & T. B. Strom: Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med, 5, 1298-302 (1999) (Pubitemid 29535608)
39. Kirk, A. D., L. C. Burkly, D. S. Batty, R. E. Baumgartner, J. D. Berning, K. Buchanan, J. H. Fechner, Jr., R. L. Germond, R. L. Kampen, N. B. Patterson, S. J. Swanson, D. K. Tadaki, C. N. TenHoor, L. White, S. J. Knechtle & D. M. Harlan: Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. Nat Med, 5, 686-93 (1999) (Pubitemid 29289433)
40. Kawai, T., D. Andrews, R. B. Colvin, D. H. Sachs & A. B. Cosimi: Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand. Nat Med, 6, 114 (2000) (Pubitemid 30082329)
41. Adams, A. B., N. Shirasugi, T. R. Jones, M. M. Durham, E. A. Strobert, S. Cowan, P. Rees, R. Hendrix, K. Price, N. S. Kenyon, D. Hagerty, R. Townsend, D. Hollenbaugh, T. C. Pearson & C. P. Larsen: Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival. J Immunol, 174, 542-50 (2005) (Pubitemid 40007445)
42. Yoshinaga, S. K., J. S. Whoriskey, S. D. Khare, U. Sarmiento, J. Guo, T. Horan, G. Shih, M. Zhang, M. A. Coccia, T. Kohno, A. Tafuri-Bladt, D. Brankow, P. Campbell, D. Chang, L. Chiu, T. Dai, G. Duncan, G. S. Elliott, A. Hui, S. M. McCabe, S. Scully, A. Shahinian, C. L. Shaklee, G. Van, T. W. Mak & G. Senaldi: T-cell costimulation through B7RP-1 and ICOS. Nature, 402, 827-32 (1999) (Pubitemid 129638129)
43. Beier, K. C., A. Hutloff, A. M. Dittrich, C. Heuck, A. Rauch, K. Buchner, B. Ludewig, H. D. Ochs, H. W. Mages & R. A. Kroczek: Induction, binding specificity and function of human ICOS. Eur J Immunol, 30, 3707-17 (2000) (Pubitemid 32005245)
44. Kopf, M., A. J. Coyle, N. Schmitz, M. Barner, A. Oxenius, A. Gallimore, J. C. Gutierrez-Ramos & M. F. Bachmann: Inducible costimulator protein (ICOS) controls T helper cell subset polarization after virus and parasite infection. J Exp Med, 192, 53-61 (2000) (Pubitemid 30470806)
45. McAdam, A. J., R. J. Greenwald, M. A. Levin, T. Chernova, N. Malenkovich, V. Ling, G. J. Freeman & A. H. Sharpe: ICOS is critical for CD40-mediated antibody class switching. Nature, 409, 102-5 (2001) (Pubitemid 32098633)
46. Tafuri, A., A. Shahinian, F. Bladt, S. K. Yoshinaga, M. Jordana, A. Wakeham, L. M. Boucher, D. Bouchard, V. S. Chan, G. Duncan, B. Odermatt, A. Ho, A. Itie, T. Horan, J. S. Whoriskey, T. Pawson, J. M. Penninger, P. S. Ohashi & T. W. Mak: ICOS is essential for effective T-helper-cell responses. Nature, 409, 105-9 (2001) (Pubitemid 32098634)
47. Coyle, A. J., S. Lehar, C. Lloyd, J. Tian, T. Delaney, S. Manning, T. Nguyen, T. Burwell, H. Schneider, J. A. Gonzalo, M. Gosselin, L. R. Owen, C. E. Rudd & J. C. Gutierrez-Ramos: The CD28-related molecule ICOS is required for effective T cell-dependent immune responses. Immunity, 13, 95-105 (2000)
48. Coyle, A. J. & J. C. Gutierrez-Ramos: The expanding B7 superfamily: increasing complexity in costimulatory signals regulating T cell function. Nat Immunol, 2, 203-9 (2001) (Pubitemid 33705995)
49. Ozkaynak, E., W. Gao, N. Shemmeri, C. Wang, J. C. Gutierrez-Ramos, J. Amaral, S. Qin, J. B. Rottman, A. J. Coyle & W. W. Hancock: Importance of ICOS-B7RP-1 costimulation in acute and chronic allograft rejection. Nat Immunol, 2, 591-6 (2001) (Pubitemid 32677625)
50. Salama, A. D., X. Yuan, A. Nayer, A. Chandraker, M. Inobe, T. Uede & M. H. Sayegh: Interaction between ICOS-B7RP1 and B7-CD28 costimulatory pathways in alloimmune responses in vivo. Am J Transplant, 3, 390-5 (2003) (Pubitemid 36560089)
51. Kosuge, H., J. Suzuki, R. Gotoh, N. Koga, H. Ito, M. Isobe, M. Inobe & T. Uede: Induction of immunologic tolerance to cardiac allograft by simultaneous blockade of inducible co-stimulator and cytotoxic T-lymphocyte antigen 4 pathway. Transplantation, 75, 1374-9 (2003)
52. Guo, L., X. K. Li, S. Enosawa, N. Funeshima, S. Suzuki, H. Kimura, Y. Sugawara, K. Tezuka & M. Makuuchi: Significant enhancement by anti-ICOS antibody of suboptimal tacrolimus immunosuppression in rat liver transplantation. Liver Transpl, 10, 743-7 (2004) (Pubitemid 38787132)
53. Nanji, S. A., W. W. Hancock, C. C. Anderson, A. B. Adams, B. Luo, C. D. Schur, R. L. Pawlick, L. Wang, A. J. Coyle, C. P. Larsen & A. M. Shapiro: Multiple combination therapies involving blockade of ICOS/B7RP-1 costimulation facilitate long-term islet allograft survival. Am J Transplant, 4, 526-36 (2004) (Pubitemid 38523575)
54. Paterson, D. J., W. A. Jefferies, J. R. Green, M. R. Brandon, P. Corthesy, M. Puklavec & A. F. Williams: Antigens of activated rat T lymphocytes including a molecule of 50, 000 Mr detected only on CD4 positive T blasts. Mol Immunol, 24, 1281-90 (1987) (Pubitemid 18008691)
55. Calderhead, D. M., J. E. Buhlmann, A. J. van den Eertwegh, E. Claassen, R. J. Noelle & H. P. Fell: Cloning of mouse Ox40: a T cell activation marker that may mediate T-B cell interactions. J Immunol, 151, 5261-71 (1993) (Pubitemid 23332335)
56. Ohshima, Y., Y. Tanaka, H. Tozawa, Y. Takahashi, C. Maliszewski & G. Delespesse: Expression and function of OX40 ligand on human dendritic cells. J Immunol, 159, 3838-48 (1997) (Pubitemid 127469639)
57. Miura, S., K. Ohtani, N. Numata, M. Niki, K. Ohbo, Y. Ina, T. Gojobori, Y. Tanaka, H. Tozawa, M. Nakamura & et al.: Molecular cloning and characterization of a novel glycoprotein, gp 34, that is specifically induced by the human T-cell leukemia virus type I transactivator p40tax. Mol Cell Biol, 11, 1313-25 (1991) (Pubitemid 21895487)
58. Takeda, I., S. Ine, N. Killeen, L. C. Ndhlovu, K. Murata, S. Satomi, K. Sugamura & N. Ishii: Distinct roles for the OX40-OX40 ligand interaction in regulatory and nonregulatory T cells. J Immunol, 172, 3580-9 (2004) (Pubitemid 38337939)
59. Yuan, X., A. D. Salama, V. Dong, I. Schmitt, N. Najafian, A. Chandraker, H. Akiba, H. Yagita & M. H. Sayegh: The role of the CD134-CD134 ligand costimulatory pathway in alloimmune responses in vivo. J Immunol, 170, 2949-55 (2003) (Pubitemid 36302166)
60. Vu, M. D., M. R. Clarkson, H. Yagita, L. A. Turka, M. H. Sayegh & X. C. Li: Critical, but conditional, role of OX40 in memory T cell-mediated rejection. J Immunol, 176, 1394-401 (2006) (Pubitemid 43134281)
61. Kwon, B. S. & S. M. Weissman: cDNA sequences of two inducible T-cell genes. Proc Natl Acad Sci U S A, 86, 1963-7 (1989) (Pubitemid 19087048)
62. Pollok, K. E., Y. J. Kim, Z. Zhou, J. Hurtado, K. K. Kim, R. T. Pickard & B. S. Kwon: Inducible T cell antigen 4-1BB. Analysis of expression and function. J Immunol, 150, 771-81 (1993) (Pubitemid 23133657)
63. Pollok, K. E., Y. J. Kim, J. Hurtado, Z. Zhou, K. K. Kim & B. S. Kwon: 4-1BB T-cell antigen binds to mature B cells and macrophages, and costimulates anti-mu-primed splenic B cells. Eur J Immunol, 24, 367-74 (1994) (Pubitemid 24041126)
64. Takahashi, C., R. S. Mittler & A. T. Vella: Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. J Immunol, 162, 5037-40 (1999) (Pubitemid 29307099)
65. Cannons, J. L., P. Lau, B. Ghumman, M. A. DeBenedette, H. Yagita, K. Okumura & T. H. Watts: 4-1BB ligand induces cell division, sustains survival, and enhances effector function of CD4 and CD8 T cells with similar efficacy. J Immunol, 167, 1313-24 (2001) (Pubitemid 32703127)
66. DeBenedette, M. A., T. Wen, M. F. Bachmann, P. S. Ohashi, B. H. Barber, K. L. Stocking, J. J. Peschon & T. H. Watts: Analysis of 4-1BB ligand (4-1BBL)-deficient mice and of mice lacking both 4-1BBL and CD28 reveals a role for 4-1BBL in skin allograft rejection and in the cytotoxic T cell response to influenza virus. J Immunol, 163, 4833-41 (1999) (Pubitemid 29501247)
67. Shuford, W. W., K. Klussman, D. D. Tritchler, D. T. Loo, J. Chalupny, A. W. Siadak, T. J. Brown, J. Emswiler, H. Raecho, C. P. Larsen, T. C. Pearson, J. A. Ledbetter, A. Aruffo & R. S. Mittler: 4-1BB costimulatory signals preferentially induce CD8+ T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses. J Exp Med, 186, 47-55 (1997) (Pubitemid 27304846)
68. Wang, J., Z. Guo, Y. Dong, O. Kim, J. Hart, A. Adams, C. P. Larsen, R. S. Mittler & K. A. Newell: Role of 4-1BB in allograft rejection mediated by CD8+ T cells. Am J Transplant, 3, 543-51 (2003) (Pubitemid 36612837)
69. Blazar, B. R., B. S. Kwon, A. Panoskaltsis-Mortari, K. B. Kwak, J. J. Peschon & P. A. Taylor: Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versusleukemia, and graft rejection in allogeneic bone marrow transplant recipients. J Immunol, 166, 3174-83 (2001) (Pubitemid 33117315)
70. Akiba, H., H. Oshima, K. Takeda, M. Atsuta, H. Nakano, A. Nakajima, C. Nohara, H. Yagita & K. Okumura: CD28-independent costimulation of T cells by OX40 ligand and CD70 on activated B cells. J Immunol, 162, 7058-66 (1999) (Pubitemid 29277673)
71. de Jong, R., W. A. Loenen, M. Brouwer, L. van Emmerik, E. F. de Vries, J. Borst & R. A. van Lier: Regulation of expression of CD27, a T cell-specific member of a novel family of membrane receptors. J Immunol, 146, 2488-94 (1991)
72. van Lier, R. A., J. Borst, T. M. Vroom, H. Klein, P. Van Mourik, W. P. Zeijlemaker & C. J. Melief: Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen. J Immunol, 139, 1589-96 (1987) (Pubitemid 17141574)
73. Hamann, D., P. A. Baars, M. H. Rep, B. Hooibrink, S. R. Kerkhof-Garde, M. R. Klein & R. A. van Lier: Phenotypic and functional separation of memory and effector human CD8+ T cells. J Exp Med, 186, 1407-18 (1997) (Pubitemid 27479800)
74. Kobata, T., S. Jacquot, S. Kozlowski, K. Agematsu, S. F. Schlossman & C. Morimoto: CD27-CD70 interactions regulate B-cell activation by T cells. Proc Natl Acad Sci U S A, 92, 11249-53 (1995)
75. Klein, U., K. Rajewsky & R. Kuppers: Human immunoglobulin (Ig) M+IgD+ peripheral blood B cells expressing the CD27 cell surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J Exp Med, 188, 1679-89 (1998) (Pubitemid 28516113)
76. Yamada, A., A. D. Salama, M. Sho, N. Najafian, T. Ito, J. P. Forman, R. Kewalramani, S. Sandner, H. Harada, M. R. Clarkson, D. A. Mandelbrot, A. H. Sharpe, H. Oshima, H. Yagita, G. Chalasani, F. G. Lakkis, H. Auchincloss, Jr. & M. H. Sayegh: CD70 signaling is critical for CD28-independent CD8+ T cell-mediated alloimmune responses in vivo. J Immunol, 174, 1357-64 (2005)
77. Linsley, P. S., W. Brady, M. Urnes, L. S. Grosmaire, N. K. Damle & J. A. Ledbetter: CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med, 174, 561-9 (1991)
78. Sayegh, M. H., E. Akalin, W. W. Hancock, M. E. Russell, C. B. Carpenter, P. S. Linsley & L. A. Turka: CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med, 181, 1869-74 (1995)
79. Turka, L. A., P. S. Linsley, H. Lin, W. Brady, J. M. Leiden, R. Q. Wei, M. L. Gibson, X. G. Zheng, S. Myrdal, D. Gordon & et al.: T-cell activation by the CD28 ligand B7 is required for cardiac allograft rejection in vivo. Proc Natl Acad Sci U S A, 89, 11102-5 (1992)
80. Lin, H., S. F. Bolling, P. S. Linsley, R. Q. Wei, D. Gordon, C. B. Thompson & L. A. Turka: Long-term acceptance of major histocompatibility complex mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med, 178, 1801-6 (1993) (Pubitemid 23318461)
81. Glysing-Jensen, T., A. Raisanen-Sokolowski, M. H. Sayegh & M. E. Russell: Chronic blockade of CD28-B7-mediated T-cell costimulation by CTLA4Ig reduces intimal thickening in MHC class I and II incompatible mouse heart allografts. Transplantation, 64, 1641-5 (1997) (Pubitemid 28041693)
82. Izawa, A., M. H. Sayegh & A. Chandraker: The antagonism of calcineurin inhibitors and costimulatory blockers: fact or fiction? Transplant Proc, 36, 570S-573S (2004) (Pubitemid 38373930)
83. Kirk, A. D., D. K. Tadaki, A. Celniker, D. S. Batty, J. D. Berning, J. O. Colonna, F. Cruzata, E. A. Elster, G. S. Gray, R. L. Kampen, N. B. Patterson, P. Szklut, J. Swanson, H. Xu & D. M. Harlan: Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates. Transplantation, 72, 377-84 (2001) (Pubitemid 32769620)
84. Kirk, A. D., D. M. Harlan, N. N. Armstrong, T. A. Davis, Y. Dong, G. S. Gray, X. Hong, D. Thomas, J. H. Fechner, Jr. & S. J. Knechtle: CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A, 94, 8789-94 (1997) (Pubitemid 27335118)
85. Birsan, T., B. Hausen, J. P. Higgins, R. W. Hubble, J. Klupp, M. Stalder, A. Celniker, S. Friedrich, R. M. O'Hara & R. E. Morris: Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys. Transplantation, 75, 2106-13 (2003) (Pubitemid 36793301)
86. Adams, A. B., N. Shirasugi, M. M. Durham, E. Strobert, D. Anderson, P. Rees, S. Cowan, H. Xu, Y. Blinder, M. Cheung, D. Hollenbaugh, N. S. Kenyon, T. C. Pearson & C. P. Larsen: Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates. Diabetes, 51, 265-70 (2002) (Pubitemid 34764779)
87. Sho, M., H. Harada, D. M. Rothstein & M. H. Sayegh: CD45RB-targeting strategies for promoting long-term allograft survival and preventingchronic allograft vasculopathy. Transplantation, 75, 1142-6 (2003) (Pubitemid 36513011)
88. Rothstein, D. M., M. F. Livak, K. Kishimoto, C. Ariyan, H. Y. Qian, S. Fecteau, M. Sho, S. Deng, X. X. Zheng, M. H. Sayegh & G. P. Basadonna: Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models. J Immunol, 166, 322-9 (2001) (Pubitemid 32038448)
89. Pearson, T. C., J. Trambley, K. Odom, D. C. Anderson, S. Cowan, R. Bray, A. Lin, D. Hollenbaugh, A. Aruffo, A. W. Siadak, E. Strobert, R. Hennigar & C. P. Larsen: Anti-CD40 therapy extends renal allograft survival in rhesus macaques. Transplantation, 74, 933-40 (2002) (Pubitemid 35191239)
90. Vincenti, F.: New monoclonal antibodies in renal transplantation. Minerva Urol Nefrol, 55, 57-66 (2003) (Pubitemid 36799018)
91. Vincenti, F., C. Larsen, A. Durrbach, T. Wekerle, B. Nashan, G. Blancho, P. Lang, J. Grinyo, P. F. Halloran, K. Solez, D. Hagerty, E. Levy, W. Zhou, K. Natarajan & B. Charpentier: Costimulation blockade with belatacept in renal transplantation. N Engl J Med, 353, 770-81 (2005) (Pubitemid 41215486)
92. Agata, Y., A. Kawasaki, H. Nishimura, Y. Ishida, T. Tsubata, H. Yagita & T. Honjo: Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int Immunol, 8, 765-72 (1996) (Pubitemid 26148299)
93. Vibhakar, R., G. Juan, F. Traganos, Z. Darzynkiewicz & L. R. Finger: Activation-induced expression of human programmed death-1 gene in T-lymphocytes. Exp Cell Res, 232, 25-8 (1997) (Pubitemid 27172215)
94. Dong, H., G. Zhu, K. Tamada & L. Chen: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med, 5, 1365-9 (1999)
95. Freeman, G. J., A. J. Long, Y. Iwai, K. Bourque, T. Chernova, H. Nishimura, L. J. Fitz, N. Malenkovich, T. Okazaki, M. C. Byrne, H. F. Horton, L. Fouser, L. Carter, V. Ling, M. R. Bowman, B. M. Carreno, M. Collins, C. R. Wood & T. Honjo: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med, 192, 1027-34 (2000)
96. Latchman, Y., C. R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A. J. Long, J. A. Brown, R. Nunes, E. A. Greenfield, K. Bourque, V. A. Boussiotis, L. L. Carter, B. M. Carreno, N. Malenkovich, H. Nishimura, T. Okazaki, T. Honjo, A. H. Sharpe & G. J. Freeman: PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol, 2, 261-8 (2001) (Pubitemid 33706004)
97. Ito, T., T. Ueno, M. R. Clarkson, X. Yuan, M. M. Jurewicz, H. Yagita, M. Azuma, A. H. Sharpe, H. Auchincloss, Jr., M. H. Sayegh & N. Najafian: Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo. J Immunol, 174, 6648-56 (2005) (Pubitemid 40705625)
98. Sandner, S. E., M. R. Clarkson, A. D. Salama, A. Sanchez-Fueyo, C. Domenig, A. Habicht, N. Najafian, H. Yagita, M. Azuma, L. A. Turka & M. H. Sayegh: Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J Immunol, 174, 3408-15 (2005) (Pubitemid 40354046)
99. Ozkaynak, E., L. Wang, A. Goodearl, K. McDonald, S. Qin, T. O'Keefe, T. Duong, T. Smith, J. C. Gutierrez-Ramos, J. B. Rottman, A. J. Coyle & W. W. Hancock: Programmed death-1 targeting can promote allograft survival. J Immunol, 169, 6546-53 (2002) (Pubitemid 36903507)
100. Yang, J., X. Yuan, N. Vadivel, T. Shin, M. H. Sayegh & A. Chandraker: The role of donor versus recipient PD-L1, a novel costimulatory molecule, in allograft rejection. American Society of Nephrology, 38th Annual Renal Week Meeting, Philadelphia (2005)
101. Watanabe, N., M. Gavrieli, J. R. Sedy, J. Yang, F. Fallarino, S. K. Loftin, M. A. Hurchla, N. Zimmerman, J. Sim, X. Zang, T. L. Murphy, J. H. Russell, J. P. Allison & K. M. Murphy: BTLA is a lymphocyte inhibitory receptor with similarities to CTLA-4 and PD-1. Nat Immunol, 4, 670-9 (2003) (Pubitemid 36874444)
102. Hurchla, M. A., J. R. Sedy, M. Gavrieli, C. G. Drake, T. L. Murphy & K. M. Murphy: B and T lymphocyte attenuator exhibits structural and expression polymorphisms and is highly Induced in anergic CD4+ T cells. J Immunol, 174, 3377-85 (2005) (Pubitemid 40354042)
103. Croft, M.: The evolving crosstalk between costimulatory and co-inhibitory receptors: HVEM-BTLA. Trends Immunol, 26, 292-4 (2005) (Pubitemid 40732659)
104. Tao, R., L. Wang, R. Han, T. Wang, Q. Ye, T. Honjo, T. L. Murphy, K. M. Murphy & W. W. Hancock: Differential effects of B and T lymphocyte attenuator and programmed death-1 on acceptance of partially versus fully MHC-mismatched cardiac allografts. J Immunol, 175, 5774-82 (2005) (Pubitemid 41508061)
105. Kosuge, H., J. Suzuki, T. Kakuta, G. Haraguchi, N. Koga, H. Futamatsu, R. Gotoh, M. Inobe, M. Isobe & T. Uede: Attenuation of graft arterial disease by manipulation of the LIGHT pathway. Arterioscler Thromb Vasc Biol, 24, 1409-15 (2004) (Pubitemid 39050433)
106. Ye, Q., C. C. Fraser, W. Gao, L. Wang, S. J. Busfield, C. Wang, Y. Qiu, A. J. Coyle, J. C. Gutierrez-Ramos & W. W. Hancock: Modulation of LIGHT-HVEM costimulation prolongs cardiac allograft survival. J Exp Med, 195, 795-800 (2002) (Pubitemid 34259724)
107. Suh, W. K., B. U. Gajewska, H. Okada, M. A. Gronski, E. M. Bertram, W. Dawicki, G. S. Duncan, J. Bukczynski, S. Plyte, A. Elia, A. Wakeham, A. Itie, S. Chung, J. Da Costa, S. Arya, T. Horan, P. Campbell, K. Gaida, P. S. Ohashi, T. H. Watts, S. K. Yoshinaga, M. R. Bray, M. Jordana & T. W. Mak: The B7 family member B7-H3 preferentially down-regulates T helper type 1-mediated immune responses. Nat Immunol, 4, 899-906 (2003) (Pubitemid 37098661)
108. Chapoval, A. I., J. Ni, J. S. Lau, R. A. Wilcox, D. B. Flies, D. Liu, H. Dong, G. L. Sica, G. Zhu, K. Tamada & L. Chen: B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol, 2, 269-74 (2001) (Pubitemid 33706005)
109. Sun, M., S. Richards, D. V. Prasad, X. M. Mai, A. Rudensky & C. Dong: Characterization of mouse and human B7-H3 genes. J Immunol, 168, 6294-7 (2002) (Pubitemid 34620050)
110. Wang L., C. C. Fraser, K. Kirkley, A. D. Wells, R. Han, A. J. Coyle, L. Chen & W. W. Hancock: B7-H3 promotes acute and chronic allograft rejection. Eur J Immunol, 35(2), 428-38 (2005) (Pubitemid 40331320)